Accretion Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 8.17 Cr
as on 23-10-2024
- Company Age 1 Year 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.53 Cr
as on 23-10-2024
About Accretion Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 8.17 Cr.
The company currently has active open charges totaling ₹8.53 Cr.
The Key Managerial Personnel (KMP) at Accretion Pharmaceuticals Limited India are Bhavika Makadia as COMPANY SECRETARY and Harshad Rathod as Cfo. Harshad Rathod, Hardik Prajapati, Mayur Sojitra, and Four other members serve as directors at the Company.
- CIN/LLPIN
U21004GJ2023PLC146545
- Company No.
146545
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2023
- Date of AGM
13 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Accretion Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Patel  | Managing Director | Current | |
| Bhavika Makadia | Company Secretary | 26-Jul-2024 | Current |
| Harshad Rathod | CFO | 26-Jul-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harshad Rathod | Director | Current | |
| Hardik Prajapati | Director | Current | |
| Mayur Sojitra | Director | Current | |
| Vijay Anadkat | Director | 26-Jul-2024 | Current |
| Shyam Kapadia | Director | 26-Jul-2024 | Current |
| Grishma Shewale | Director | 26-Jul-2024 | Current |
Financial Performance of Accretion Pharmaceuticals.
Accretion Pharmaceuticals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Accretion Pharmaceuticals?
In 2024, Accretion Pharmaceuticals had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Accretion Nutraveda Private LimitedActive 3 years 9 monthsHarshad Rathod, Hardik Prajapati and 2 more are mutual person
- Accresha Lifecare Private LimitedActive 3 years 1 month
Hardik Prajapati and Mayur Sojitra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 05 Jan 2024 | ₹8.53 Cr | Open |
How Many Employees Work at Accretion Pharmaceuticals?
Accretion Pharmaceuticals has a workforce of 0 employees as of Oct 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accretion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accretion Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
